Alex Gaither manages a drug discovery team and several drug target validation projects at Novartis. His team’s mission is to identify novel oncogenes to validate their functional role and investigate their feasibility as therapeutic targets feasibility. A core team of researchers supports the portfolio validation process, including five biology labs, a histopathology group, quantitative biology […]